Search

Resonance Health extends distribution deal with Novartis

Claremont-based magnetic resonance imaging technology developer Resonance Health Ltd has extended the distribution deal for its liver iron monitoring device FerriScan with Switzerland-based Novartis AG, the company has announced.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/10/18

1 year TSR5 year TSR
46thiCollege100%-12%
79thResonance Health67%20%
661stDe.Mem-47%0%
672ndDepartment 13 International-49%-23%
673rdEphraim Resources-49%-23%
744 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

06/09/18
$32k Bought
29/05/18
$2k Bought
23/05/18
$4k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

115th↓iCollege$3.1m
116th↑De.Mem$2.9m
117th↓Resonance Health$2.9m
118th↑Department 13 International$2.9m
119th↑Ephraim Resources$2.9m
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer